Karp Alexander C.

Palantir insider Karp Alexander C. sold 90,000 shares for $12.1M under 10b5-1 plan on 2026-02-20

Karp Alexander C. executed 5 separate sales totaling 90,000 shares for $12,064,116.89 at prices ranging from $132.01 to $135.67, reducing his holdings from 6,522,258 shares to 6,432,258 shares (a 1.4% reduction). This transaction was conducted under a pre-arranged 10b5-1 trading plan, making it a scheduled, non-discretionary sale rather than a discretionary choice. The filing includes a derivative-conversion element that means his Table I common-share position does not reflect his total holdings. The blended average sale price of $134.05 across the five tranches represents execution at incremental price points on the filing date, characteristic of algorithmic or scheduled-plan execution rather than a concentrated tactical decision.

Karp sells 2,102,636 shares for $132,851,232.41 at Palantir under 10b5-1 plan

Karp Alexander C. executed 4 separate sales totaling 2,102,636 shares for $132,851,232.41 across two trading days (November 21–22, 2024) at prices ranging from $62.13 to $63.98, with a blended average price of $63.18. The transactions are part of a pre-arranged 10b5-1 trading plan, meaning they were scheduled in advance rather than discretionary. Post-transaction holdings stand at 6,432,258 shares, down 24.6% from the pre-transaction total of 8,534,894 shares. Because this filing involves a derivative-conversion transaction (Table II), the reported Table I position does not reflect Karp's total beneficial interest in PLTR. The scheduled nature of this activity removes any timing characterization from analysis; investors should note the magnitude of the disposition and cross-reference derivative holdings once Table II data is available to assess the full economic exposure.

Karp sold 1,144,069 shares (1.14M) of PLTR for $73,044,303.16 across 4 sales 11/18–11/20, per 10b5-1 plan

Karp Alexander C. executed 4 separate sales totaling 1,144,069 shares for $73,044,303.16 at a blended average price of $63.85, reducing holdings from 7,576,327 to 6,432,258 shares (a 15.1% reduction). This transaction was executed under a pre-arranged 10b5-1 trading plan, indicating the sales were scheduled rather than discretionary. The filing contains a derivative conversion component (Table II), meaning the reported post-transaction holdings do not reflect the insider's full economic position in derivative securities. Investors should note that this sale represents a mechanical execution of a pre-planned schedule and does not necessarily reflect discretionary portfolio decisions made at current valuations.

Karp sells 6.32M shares for $399.1M across 2 transactions under 10b5-1 plan at $63.10-$63.12

Karp Alexander C. executed 2 separate sales totaling 6,323,602 shares for $399,064,043.27 at a blended average price of $63.11 under a pre-arranged 10b5-1 trading plan. The sales reduced his equity holdings by 49.6% from 12,755,860 shares to 6,432,258 shares post-transaction. As a scheduled transaction under a 10b5-1 plan, this sale reflects a pre-determined trading schedule rather than a discretionary market-driven decision. The magnitude of the sale ($399.1M across two tranches) and the reduction of nearly half his common equity position warrant investor attention to understand the underlying strategic or operational context, though the planned nature of the execution limits any inference about near-term sentiment or price expectations.

Karp sells 12.34M shares for $650.6M across 6 transactions (Nov 5-7); executes 10b5-1 plan

Alexander C. Karp executed 6 separate sales totaling 12,343,707 shares for $650,638,388.31 between November 5–7, 2024, at prices ranging from $47.49 to $56.12. This transaction is part of a pre-arranged 10b5-1 trading plan and therefore is scheduled rather than discretionary. The filing reports derivative-conversion activity, meaning Karp's full position extends into Table II holdings not yet populated in the database; the post-transaction Table I balance of 6,432,258 shares does not represent his total equity interest. The sale reduced his Table I holdings by 65.7% from 18,775,965 shares pre-transaction, reflecting a material reduction of his direct stock position at Palantir.

Karp sells 5,656,293 shares for $254.6M under 10b5-1 plan at blended avg $45.01

Karp Alexander C. executed 3 separate sales totaling 5,656,293 shares for $254,610,669.37 across October 25–29, 2024, reducing his holdings from 12,088,551 to 6,432,258 shares. This represents a -46.8% reduction in his Table I common shareholding. The sales were conducted under a pre-arranged 10b5-1 trading plan and are therefore scheduled rather than discretionary. The filing notes a derivative-conversion component, indicating part of Karp's position resides in Form 4 Table II (derivative securities not yet populated in the database), so the common shares shown do not represent his total beneficial ownership. As a co-founder and key executive at Palantir, large share dispositions are material events, but the scheduled nature of the 10b5-1 plan means these sales reflect execution of a predetermined trading arrangement rather than a discretionary market response.

Karp sells 9,000,000 shares of PLTR across 4 transactions for $325,584,089.64 under 10b5-1 plan

Karp Alexander C. executed 4 separate sales totaling 9,000,000 shares for $325,584,089.64 at prices ranging from $36.00 to $37.04, reducing his holdings from 15,432,258 shares to 6,432,258 shares. This represents a net reduction of 58.3% of his pre-transaction holdings. The transaction is part of a pre-arranged 10b5-1 trading plan, meaning the sales were scheduled and non-discretionary rather than driven by current market judgment. The filing indicates derivative security conversions that are not yet reflected in Table I, so the post-transaction share count of 6,432,258 shares does not represent his total economic position.

Palantir (PLTR) insider Karp Alexander C. sold 575,072 shares across 2 transactions for $18.5M via 10b5-1 plan

Karp Alexander C. executed 2 separate sales totaling 575,072 shares (575.1K shares) for $18,529,759.90 on 2024-08-22, reducing holdings from 7,007,330 shares (7.01M shares) to 6,432,258 shares (6.43M shares), a -8.2% reduction in stake size. The sales were executed under a pre-arranged 10b5-1 trading plan, meaning they were scheduled and not discretionary. This filing also involves a derivative-conversion transaction, so the Table I holdings shown do not represent the insider's complete position; additional derivative securities in Table II may be held. The blended average sale price was $32.22 across the two transactions.